Pharmaceutical Raw Materials 99% Azithromycin Powder
Related Attributes
Product details
Azithromycin Powder 99% Raw Materials, High Quality Pharmaceutical Raw Materials 99% Azithromycin Powder CAS 83905-01-5.China API Raw Materials Supplier and Manufacturer in China,Wholesale Azithromycin Powder Raw Materials, Bulk high quality Azithromycin Powder for sale.
Azithromycin, commonly used dosage forms for dry suspension, tablets, dispersed tablets, capsules, granules, injections. Is an antimicrobial drug. It is used to treat acute pharyngitis and acute tonsillitis caused by Streptococcus pyogenes. Sensitive bacteria caused by sinusitis, otitis media, acute bronchitis, chronic bronchitis acute attack; Streptococcus pneumoniae, Haemophilus influenzae and pneumonia caused by Mycoplasma pneumoniae, etc.
Azithromycin is used for:1. Acute pharyngitis and acute tonsillitis caused by Streptococcus pyogenes.
2. Acute attacks of sinusitis, otitis media, acute bronchitis and chronic bronchitis caused by sensitive bacteria.
3. Pneumonia caused by Streptococcus pneumoniae, Haemophilus influenzae and Mycoplasma pneumoniae.
4. Urethritis and cervicitis caused by Chlamydia trachomatis and non-multidrug-resistant Neisseria gonorrhoeae.
5. Skin and soft tissue infections caused by sensitive bacteria.
Azithromycin is an azolactone antibiotic that acts by binding to the subunit of the 50S ribosome of sensitive microorganisms, thereby interfering with their protein synthesis (without affecting nucleic acid synthesis). In vitro and clinical studies have shown that azithromycin is effective against the following pathogens:
1. Gram-positive aerobic microorganisms: Staphylococcus aureus, Streptococcus pyostreptococcus, Streptococcus pneumoniae, hemolytic streptococcus.
2. Azithromycin is cross-resistant to erythromycin-resistant gram-positive bacteria. Most Streptococcus faecalis (enterococcus) and methicillin-resistant staphylococcus are resistant to this product.
3. Gram-negative aerobic microorganisms: Haemophilus influenzae, Moraxella kataxa, Mycoplasma trachomatis. In vitro tests and clinical studies have confirmed that azithromycin prevents disease caused by Mycobacterium avium complex (consisting of Mycobacterium avium and Mycobacterium avium).
4. Azithromycin had no effect on β-lactamase producing strains. There have been in vitro studies on the following microorganisms, but their clinical significance is not clear, including Streptococcus (C, F, G), Streptococcus aeruginosa, Bacillus pertussis, Haemophilus duque, Legionella pneumophila, Bacillus, Streptococcus digester, Borrelia pallidum, Chlamydia pneumoniae, Treponema pallidum, ureaplasma uticulium, etc.
Why choose us?
HRK Factory
About Shipping
Home
E-mail
Booking